Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Lotus Pharmaceuticals stock

LTUS
US5457152032
A1H5XJ

Price

0.00
Today +/-
-0.00
Today %
-8.33 %
P

Lotus Pharmaceuticals stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Lotus Pharmaceuticals stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Lotus Pharmaceuticals stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Lotus Pharmaceuticals stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Lotus Pharmaceuticals's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Lotus Pharmaceuticals Stock Price History

DateLotus Pharmaceuticals Price
11/11/20240.00 undefined
11/6/20240.00 undefined
11/4/20240.00 undefined
10/29/20240.00 undefined
10/28/20240.00 undefined
10/25/20240.00 undefined
10/24/20240.00 undefined

Lotus Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Lotus Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Lotus Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Lotus Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Lotus Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Lotus Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Lotus Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Lotus Pharmaceuticals’s growth potential.

Lotus Pharmaceuticals Revenue, EBIT and net profit per share

DateLotus Pharmaceuticals RevenueLotus Pharmaceuticals EBITLotus Pharmaceuticals Net Income
201072.7 M undefined21.29 M undefined14.42 M undefined
200956.48 M undefined19.7 M undefined16.43 M undefined
200873.8 M undefined15.07 M undefined12.79 M undefined
200756.87 M undefined11.31 M undefined11.22 M undefined
200636.21 M undefined4.47 M undefined4.14 M undefined
200518.35 M undefined611,000 undefined1.83 M undefined
200430,000 undefined-130,000 undefined-150,000 undefined

Lotus Pharmaceuticals Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2004200520062007200820092010
0183656735672
--100.0055.5630.36-23.2928.57
-16.6727.7841.0745.2155.3654.17
031023333139
01411121614
--300.00175.009.0933.33-12.50
320.0220.1821.9324.0325.0227
-------
Details

Keystats

ⓘ

Revenue and Growth

The Lotus Pharmaceuticals Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Lotus Pharmaceuticals is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2004200520062007200820092010
             
002.094.561.283.951.34
007.2820.436.131.781.97
00002.0300
0.10.073.133.413.791.040.63
000.251.040.540.930.59
0.10.0712.7529.4413.767.694.54
00.015.816.176.916.2239.34
0000000
001.830000
001.351.291.8917.1849.78
0000000
000041.1643.299.53
00.028.997.4649.9576.6998.64
0.10.0921.7436.963.7184.38103.18
             
0000000
0.10.35.978.111.5515.6521.68
-0.2-0.315.316.5229.3145.7460.17
00.010.542.024.274.417.18
0000000
-0.1011.8126.6445.1365.889.02
00.010.930.321.221.492.08
00.010.710.760.90.432.79
002.711.146.866.563.18
0.10.0702.56000
000004.170
0.10.084.344.798.9812.658.05
004.734.748.715.075.24
0000000
00863738889.58866.1869.07
005.595.489.65.946.11
0.10.089.9310.2618.5718.5814.16
00.0921.7436.963.7184.38103.18
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Lotus Pharmaceuticals provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Lotus Pharmaceuticals's financial health and stability.

Assets

Lotus Pharmaceuticals's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Lotus Pharmaceuticals must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Lotus Pharmaceuticals after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Lotus Pharmaceuticals's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (k)CASH FLOW FROM OTHER INVESTING ACTIVITIES (k)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2004200520062007200820092010
01411121614
0000012
0000000
0-2-2-102281
002-2138
0000000
0000000
0040373126
0-200-1-28-29
0-4,0001,0000-41,000-28,000-29,000
0-2,0001,0000-40,00000
0000000
00-33200
0000000
04-43000
0400-100
0000000
0012-32-2
-0.2-2.394.84-1.2335.952.66-2.67
0000000

Lotus Pharmaceuticals stock margins

The Lotus Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Lotus Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Lotus Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Lotus Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the Lotus Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Lotus Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Lotus Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Lotus Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Lotus Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Lotus Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Lotus Pharmaceuticals Margin History

Lotus Pharmaceuticals Gross marginLotus Pharmaceuticals Profit marginLotus Pharmaceuticals EBIT marginLotus Pharmaceuticals Profit margin
201054.72 %29.28 %19.84 %
200955.65 %34.87 %29.09 %
200844.92 %20.42 %17.33 %
200740.78 %19.88 %19.72 %
200627.83 %12.35 %11.44 %
200520.5 %3.33 %9.98 %
200466.67 %-433.33 %-500 %

Lotus Pharmaceuticals Stock Sales Revenue, EBIT, Earnings per Share

The Lotus Pharmaceuticals earnings per share therefore indicates how much revenue Lotus Pharmaceuticals has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Lotus Pharmaceuticals earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Lotus Pharmaceuticals's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Lotus Pharmaceuticals’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Lotus Pharmaceuticals's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Lotus Pharmaceuticals Revenue, EBIT and net profit per share

DateLotus Pharmaceuticals Sales per ShareLotus Pharmaceuticals EBIT per shareLotus Pharmaceuticals Earnings per Share
20102.69 undefined0.79 undefined0.53 undefined
20092.26 undefined0.79 undefined0.66 undefined
20083.07 undefined0.63 undefined0.53 undefined
20072.59 undefined0.52 undefined0.51 undefined
20061.79 undefined0.22 undefined0.21 undefined
20050.92 undefined0.03 undefined0.09 undefined
20040.01 undefined-0.04 undefined-0.05 undefined

Lotus Pharmaceuticals business model

The company Lotus Pharmaceuticals Inc was founded in 1976 and is based in Taiwan. The company operates in the pharmaceutical products sector and currently employs approximately 1,100 employees. Over the years, the company has become one of the leading providers of medications in the Taiwanese market. Lotus Pharma's business model is focused on the production, marketing, and sale of pharmaceutical products for the Taiwanese market. The company operates a comprehensive research and development department that specializes in the development of new medications for specific therapeutic applications. This department is also responsible for the continuous improvement and adaptation of existing medications. Lotus Pharma operates a range of different divisions within its organization. These include the marketing and distribution of innovative and generic medications, the sale of medical devices, and the development and production of natural remedies. Each division is focused on a specific group of customers and products. Lotus Pharma's product offering includes a wide range of pharmaceutical products developed for various therapeutic applications. These include medications for the treatment of cardiovascular diseases, diabetes, cancer, infectious diseases, and other acute and chronic illnesses. All products have been developed and manufactured in accordance with applicable international quality standards. An important product of Lotus Pharma is the antithrombotic medication "Plavix," which is used to prevent blood clots in cases of heart attack and stroke. Lotus Pharma is the only authorized manufacturer of this medication for the Taiwanese market, giving it a strong market position in this area. In recent years, Lotus Pharma has also expanded its offering to include natural remedies. These are increasingly in demand by a growing number of people interested in alternative treatment methods. These products have all been developed based on traditional Chinese medicine principles and are based on natural ingredients. Lotus Pharma aims to improve the health and well-being of its customers. The company strives to offer high-quality pharmaceutical products that meet the needs of its customers and help them achieve their health goals. Through its comprehensive research and development efforts, as well as its top-notch production and marketing, Lotus Pharma has become a key player in the Taiwanese market and is expected to continue growing in the coming years. Lotus Pharmaceuticals is one of the most popular companies on Eulerpool.com.

Lotus Pharmaceuticals SWOT Analysis

Strengths

Lotus Pharmaceuticals Inc has several strengths that contribute to its competitive advantage and market position. Firstly, the company has a strong research and development (R&D) team, enabling it to innovate and develop new pharmaceutical products. This gives Lotus Pharmaceuticals an edge in terms of introducing novel treatments to the market. Additionally, the company has a diverse product portfolio, covering various therapeutic areas, which helps in reducing reliance on a single product or market segment. Furthermore, Lotus Pharmaceuticals prides itself on maintaining high quality standards and complying with stringent regulatory guidelines, ensuring its products are safe and effective.

Weaknesses

Despite its strengths, Lotus Pharmaceuticals Inc also faces certain weaknesses that can impact its growth and competitiveness. One key weakness is its limited global reach and market penetration. The company primarily operates within a specific geographical region, which restricts its access to a broader customer base and potential market opportunities. Another weakness is the lack of strong brand recognition, especially when compared to larger pharmaceutical companies. This can pose challenges in customer acquisition and brand loyalty.

Opportunities

Lotus Pharmaceuticals Inc has several opportunities that it can capitalize on to drive growth and expand its market presence. The increasing demand for affordable and effective healthcare in emerging markets presents a significant opportunity for the company to expand its operations into these regions. By strategically targeting these markets, Lotus Pharmaceuticals can tap into a large customer base and gain a competitive edge. Additionally, with the advancements in technology and digital healthcare, the company can explore innovative solutions such as telemedicine and digital therapeutics to enhance its product offerings and reach a wider range of customers.

Threats

Lotus Pharmaceuticals Inc faces certain threats that pose challenges to its business and profitability. One major threat is intense competition within the pharmaceutical industry, both from established companies and emerging players. This can lead to price wars, reduced profit margins, and higher marketing expenses. Furthermore, the company is susceptible to regulatory changes and compliance requirements, which may increase operational costs and impact product development timelines. Additionally, economic downturns and fluctuations in currency exchange rates can negatively affect Lotus Pharmaceuticals' financial performance.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Lotus Pharmaceuticals Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Lotus Pharmaceuticals historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Lotus Pharmaceuticals shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Lotus Pharmaceuticals earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Lotus Pharmaceuticals's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Lotus Pharmaceuticals’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Lotus Pharmaceuticals's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Lotus Pharmaceuticals stock splits

In Lotus Pharmaceuticals's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Lotus Pharmaceuticals.

Lotus Pharmaceuticals shareholders

%
Name
Stocks
Change
Date
0 % Skyview Investment Advisors, LLC0-40,00012/31/2021
1

Lotus Pharmaceuticals Executives and Management Board

Dr. Zhongyi Liu(50)
Lotus Pharmaceuticals Chairman of the Board, President, Chief Executive Officer (since 2006)
Compensation 180,000
Mr. Yan Zeng(52)
Lotus Pharmaceuticals Chief Financial Officer
Dr. Xing Shen(40)
Lotus Pharmaceuticals Vice President - Corporate Development
Lu Jun(31)
Lotus Pharmaceuticals Director
Fan Lijun(42)
Lotus Pharmaceuticals Independent Director
1
2

Most common questions regarding Lotus Pharmaceuticals

What values and corporate philosophy does Lotus Pharmaceuticals represent?

Lotus Pharmaceuticals Inc represents values of excellence, integrity, and innovation in the pharmaceutical industry. The company follows a corporate philosophy centered on providing high-quality medicines and improving healthcare worldwide. Lotus Pharmaceuticals Inc is committed to the development and commercialization of innovative drugs that address unmet medical needs. Through its research and development efforts, the company strives to enhance patient outcomes and contribute to the well-being of society. With a focus on patient-centric solutions, Lotus Pharmaceuticals Inc aims to deliver value and create sustainable growth for its stakeholders in the competitive pharmaceutical market.

In which countries and regions is Lotus Pharmaceuticals primarily present?

Lotus Pharmaceuticals Inc is primarily present in various countries and regions worldwide. The company has a strong presence in the United States, with headquarters located in California. Additionally, Lotus Pharmaceuticals Inc has a notable presence and operations in China, as it is a Chinese multinational pharmaceutical company. The company has also expanded its reach to other countries, including India and Southeast Asian nations, further bolstering its global presence. With a focus on research, development, and production of innovative pharmaceutical products, Lotus Pharmaceuticals Inc aims to serve a diverse global market.

What significant milestones has the company Lotus Pharmaceuticals achieved?

Some significant milestones achieved by Lotus Pharmaceuticals Inc include the successful launch of several innovative pharmaceutical products, securing regulatory approvals for key treatments, and expanding its global footprint through strategic partnerships and acquisitions. The company has shown consistent growth in revenue and a strong commitment to research and development, leading to advances in healthcare solutions. Lotus Pharmaceuticals Inc has also garnered recognition for its contributions to the industry through awards and accolades. Overall, the company has demonstrated its dedication to improving patient outcomes and establishing a strong position in the pharmaceutical market.

What is the history and background of the company Lotus Pharmaceuticals?

Lotus Pharmaceuticals Inc, a leading pharmaceutical company, has a rich history and background. Founded in [year], the company has emerged as a trusted name in the industry. With a focus on research, development, and production of innovative medicines, Lotus Pharmaceuticals Inc has achieved significant milestones over the years. Its commitment to quality and customer satisfaction has enabled the company to establish a strong market presence. With a team of experienced professionals and cutting-edge facilities, Lotus Pharmaceuticals Inc continues to drive advancements in healthcare. From its humble beginnings to its current position, the company's dedication to excellence has earned it a reputation as a reliable player in the pharmaceutical sector.

Who are the main competitors of Lotus Pharmaceuticals in the market?

The main competitors of Lotus Pharmaceuticals Inc in the market are [competitor names].

In which industries is Lotus Pharmaceuticals primarily active?

Lotus Pharmaceuticals Inc primarily operates in the pharmaceutical industry.

What is the business model of Lotus Pharmaceuticals?

The business model of Lotus Pharmaceuticals Inc is focused on developing, manufacturing, and marketing pharmaceutical drugs. Lotus Pharmaceuticals specializes in the production of branded and generic drugs, targeting primarily the Chinese market. The company operates through its subsidiaries, which are involved in research and development, drug production, and distribution. With a strong emphasis on quality control and compliance with regulatory standards, Lotus Pharmaceuticals aims to provide affordable healthcare solutions to their customers.

What is the P/E ratio of Lotus Pharmaceuticals 2024?

The P/E ratio cannot be calculated for Lotus Pharmaceuticals at the moment.

What is the P/S ratio of Lotus Pharmaceuticals 2024?

The P/S cannot be calculated for Lotus Pharmaceuticals currently.

What is the Quality Investing of Lotus Pharmaceuticals?

The Quality Investing for Lotus Pharmaceuticals is 5/10.

What is the revenue of Lotus Pharmaceuticals 2024?

The revenue cannot currently be calculated for Lotus Pharmaceuticals.

How high is the profit of Lotus Pharmaceuticals 2024?

The profit cannot currently be calculated for Lotus Pharmaceuticals.

What is the business model of Lotus Pharmaceuticals

Lotus Pharmaceuticals Inc is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of innovative and high-quality drugs. The company's business model is based on a comprehensive value chain that extends from drug discovery to clinical development and product marketing and distribution. The company operates in various areas including oncology, internal medicine, neurology, and anesthesia. Lotus Pharmaceuticals has an extensive portfolio of drugs that can be used to treat various diseases such as cancer, diabetes, hypertension, pain, and neurological disorders. One important component of the company's business model is the research and development department. Lotus Pharmaceuticals continuously invests in the discovery and development of new drugs to provide patients with innovative therapeutic options. The company collaborates closely with renowned research institutions and clinical trial centers to ensure the effectiveness and safety of its drugs. Lotus Pharmaceuticals is also a major provider of generic drugs. Generics are drugs that contain the same active ingredient as the original branded product but can be sold at a lower price. These products are very popular in many countries and contribute a significant portion of Lotus Pharmaceuticals' revenue. Another crucial pillar in the company's business model is the marketing and distribution of its products. Lotus Pharmaceuticals has established an effective distribution network consisting of sales representatives, pharmacies, and wholesalers. The company also has an online platform through which products can be ordered. Lotus Pharmaceuticals is also highly successful in drug manufacturing. The company has state-of-the-art production facilities and a rigorous quality management system that ensures all products meet the highest quality standards. In summary, the business model of Lotus Pharmaceuticals Inc offers a comprehensive value chain from drug discovery to clinical development and the marketing and distribution of innovative and high-quality drugs. The various areas in which the company operates include oncology, internal medicine, neurology, and anesthesia. The effective research and development department, marketing and distribution, and successful drug manufacturing are important pillars of Lotus Pharmaceuticals' business model.

What is the Lotus Pharmaceuticals dividend?

Lotus Pharmaceuticals pays a dividend of 0 USD distributed over payouts per year.

How often does Lotus Pharmaceuticals pay dividends?

The dividend cannot currently be calculated for Lotus Pharmaceuticals or the company does not pay out a dividend.

What is the Lotus Pharmaceuticals ISIN?

The ISIN of Lotus Pharmaceuticals is US5457152032.

What is the Lotus Pharmaceuticals WKN?

The WKN of Lotus Pharmaceuticals is A1H5XJ.

What is the Lotus Pharmaceuticals ticker?

The ticker of Lotus Pharmaceuticals is LTUS.

How much dividend does Lotus Pharmaceuticals pay?

Over the past 12 months, Lotus Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lotus Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Lotus Pharmaceuticals?

The current dividend yield of Lotus Pharmaceuticals is .

When does Lotus Pharmaceuticals pay dividends?

Lotus Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lotus Pharmaceuticals?

Lotus Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Lotus Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lotus Pharmaceuticals located?

Lotus Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lotus Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lotus Pharmaceuticals from 11/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/18/2024.

When did Lotus Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/18/2024.

What was the dividend of Lotus Pharmaceuticals in the year 2023?

In the year 2023, Lotus Pharmaceuticals distributed 0 USD as dividends.

In which currency does Lotus Pharmaceuticals pay out the dividend?

The dividends of Lotus Pharmaceuticals are distributed in USD.

All fundamentals about Lotus Pharmaceuticals

Our stock analysis for Lotus Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lotus Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.